Chromosomal Abnormalities in Cancer

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817 · see citing works

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439 · see citing works

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496 · see citing works

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291 · see citing works

Frequent deletions and down-regulation of micro- RNA genes <i>miR15</i> and <i>miR16</i> at 13q14 in chronic lymphocytic leukemia

Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 4,269 · see citing works

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096 · see citing works

Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate Cancer

Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846 · see citing works

miR-15 and miR-16 induce apoptosis by targeting BCL2

Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,510 · see citing works

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Druker, B. J., Guilhot, F., O’Brien, S. G., Gathmann, I., Kantarjian, H. M., Gattermann, N., Deininger, M. W., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,473 · see citing works

Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432602 · Cited by 3,316 · see citing works

Epidermal growth factor receptor mutations in lung cancer

Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170 · see citing works

Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104 · see citing works

Trastuzumab — Mechanism of Action and Use in Clinical Practice

Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,592 · see citing works

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · see citing works

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan‐Smith, E., Dalton, J., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,798 · see citing works

Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D. J., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,785 · see citing works

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

Talpaz, M., Shah, N. P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., Cortes, J., O'Brien, S., Nicaise, C., Bleickardt, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055229 · Cited by 1,760 · see citing works

A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Cools, J., DeAngelo, D. J., Gotlib, J. R., Stover, E. H., Legare, R. D., Cortes, J. E., Kutok, J. L., Clark, J., Galinsky, I. A., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,704 · see citing works

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

Groffen, J., Stephenson, J. R., Heisterkamp, N., DeKlein, A., Bartram, C., & Grosveld, G. C. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,578 · see citing works

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548 · see citing works

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Weisberg, E., Manley, P. W., Breitenstein, W., Brüggen, J., Cowan‐Jacob, S. W., Ray, A., Huntly, B. J. P., Fabbro, D., Fendrich, G., Hall–Meyers, E., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.007 · Cited by 1,494 · see citing works

Chromosomal translocations in human cancer

Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,490 · see citing works

The impact of translocations and gene fusions on cancer causation

Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400 · see citing works

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378 · see citing works

Tyrosine Kinases as Targets for Cancer Therapy

Krause, D. S., & Etten, R. A. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044389 · Cited by 1,376 · see citing works

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

Kantarjian, H. M., Giles, F. J., Wunderle, L., Bhalla, K. N., O'Brien, S. M., Waßmann, B., Tanaka, C., Manley, P. W., Rae, P., Mietlowski, W. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055104 · Cited by 1,334 · see citing works

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319 · see citing works

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,288 · see citing works

Acute promyelocytic leukemia: from highly fatal to highly curable

Wang, Z., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,283 · see citing works

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,272 · see citing works

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

Deininger, M. W., Buchdunger, E., & Druker, B. J. (2004) · Blood · doi:10.1182/blood-2004-08-3097 · Cited by 1,252 · see citing works

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

Hughes, T. (2006) · Blood · doi:10.1182/blood-2006-01-0092 · Cited by 1,197 · see citing works

Transcription factors as targets for cancer therapy

Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · see citing works

Two genetic hits (more or less) to cancer

Knudson, A. G. (2001) · Nature reviews. Cancer · doi:10.1038/35101031 · Cited by 1,122 · see citing works

Characterizing the cancer genome in lung adenocarcinoma

Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105 · see citing works

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072 · see citing works

Chromosome Studies on Normal and Leukemic Human Leukocytes

Nowell̀, P. C., & Hungerford, D. A. (1960) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/25.1.85 · Cited by 1,066 · see citing works

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065 · see citing works

microRNAs exhibit high frequency genomic alterations in human cancer

Zhang, L., Huang, J., Yang, N., Greshock, J. D., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,032 · see citing works

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR

Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B. L., THOMAS, G. V., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 968 · see citing works

Mechanisms of B-cell lymphoma pathogenesis

Küppers, R. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1589 · Cited by 966 · see citing works

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

Goldman, J. M., & Melo, J. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020777 · Cited by 946 · see citing works

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Ebert, B. L., Pretz, J. L., Bosco, J., Chang, C. Y., Tamayo, P., Galili, N., Raza, A., Root, D. E., Attar, E. C., Ellis, S. R., et al. (2008) · Nature · doi:10.1038/nature06494 · Cited by 925 · see citing works

The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway

Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 922 · see citing works

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

Tomlins, S., Laxman, B., Dhanasekaran, S., Helgeson, B. E., Cao, X.-H., Morris, D. S., Menon, A., Jing, X.-J., Cao, Q., Han, B., et al. (2007) · Nature · doi:10.1038/nature06024 · Cited by 904 · see citing works

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., & Grosveld, G. C. (1983) · Nature · doi:10.1038/306239a0 · Cited by 833 · see citing works

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG

Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D. H., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747 · see citing works

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Cairncross, G. J., Berkey, B. A., Shaw, E., Jenkins, R. B., Scheithauer, B. W., Brachman, D. G., Buckner, J. C., Fink, K., Souhami, L., Laperierre, N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3414 · Cited by 726 · see citing works

Origins of chromosome translocations in childhood leukaemia

Greaves, M. F., & Wiemels, J. L. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1164 · Cited by 701 · see citing works

Cytogenetics in acute leukemia

Mrózek, K., Heerema, N. A., & Bloomfield, C. D. (2003) · Blood Reviews · doi:10.1016/s0268-960x(03)00040-7 · Cited by 668 · see citing works

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J. M., Yudi Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 646 · see citing works

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Apperley, J. F., Gardembas, M., Melo, J. V., Russell‐Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 632 · see citing works

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma

Cloughesy, T. F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., Youngkin, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050008 · Cited by 593 · see citing works

Array comparative genomic hybridization and its applications in cancer

Pinkel, D., & Albertson, D. G. (2005) · Nature Genetics · doi:10.1038/ng1569 · Cited by 585 · see citing works

TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer

Perner, S., Demichelis, F., Beroukhim, R., Schmidt, F. H., Mosquera, J. M., Setlur, S. R., Tchinda, J., Tomlins, S. A., Hofer, M. D., Pienta, K. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1482 · Cited by 501 · see citing works

A Genetic Screen for Candidate Tumor Suppressors Identifies REST

Westbrook, T. F., Martin, E. S., Schlabach, M. R., Leng, Y., Liang, A. C. T., Feng, B., Zhao, J. J., Roberts, T. M., Mandel, G., Hannon, G. J., et al. (2005) · Cell · doi:10.1016/j.cell.2005.03.033 · Cited by 487 · see citing works

<i>TMPRSS2:ETV4</i> Gene Fusions Define a Third Molecular Subtype of Prostate Cancer

Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469 · see citing works

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A. A., Levine, R. L., Vermeesch, J. R., Stul, M. S., Dutta, B., Boeckx, N., et al. (2004) · Nature Genetics · doi:10.1038/ng1425 · Cited by 434 · see citing works

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

Perner, S., Mosquera, J. M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J. P., Collins, C. C., Bismar, T. A., Chinnaiyan, A. M., Marzo, A. M. D., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213424.38503.aa · Cited by 425 · see citing works

A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer

Laxman, B., Morris, D. S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R. J., Tsodikov, A., Wei, J. T., Tomlins, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3224 · Cited by 407 · see citing works

THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS

Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 392 · see citing works

Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene

Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon‐Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 390 · see citing works

Molecular pathogenesis of Fanconi anemia: recent progress

Taniguchi, T., & D’Andrea, A. D. (2006) · Blood · doi:10.1182/blood-2005-10-4240 · Cited by 387 · see citing works

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

Zabarovsky, E. R., Lerman, M. I., & Minna, J. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205835 · Cited by 383 · see citing works

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer

Holst, F., Stahl, P. R., Ruiz, C. F., Hellwinkel, O., Jehan, Z., Wendland, M., Lebeau, A., Terracciano, L., Al-Kuraya, K. S., Jänicke, F., et al. (2007) · Nature Genetics · doi:10.1038/ng2006 · Cited by 376 · see citing works

An X Chromosome Gene, WTX , Is Commonly Inactivated in Wilms Tumor

Rivera, M. N., Kim, W. J., Wells, J. M., Driscoll, D. R., Brannigan, B. W., Han, M., Kim, J. C., Feinberg, A. P., Gerald, W. L., Vargas, S. O., et al. (2007) · Science · doi:10.1126/science.1137509 · Cited by 339 · see citing works

The Biology of Ewing sarcoma

Riggi, N., & Stamenkovic, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.009 · Cited by 283 · see citing works

Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer

Helgeson, B. E., Tomlins, S. A., Shah, N., Laxman, B., Cao, Q., Prensner, J. R., Cao, X., Singla, N., Montie, J. E., Varambally, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5352 · Cited by 276 · see citing works

Narrowing and genomic annotation of the commonly deleted region of the 5q− syndrome

Boultwood, J., Fidler, C., Strickson, A., Watkins, F., Gama, S., Kearney, L., Tosi, S., Kasprzyk, A., Cheng, J., Jaju, R. J., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4638 · Cited by 264 · see citing works

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

Nam, R. K., Sugar, L., Yang, W., Srivastava, S. K., Klotz, L., Yang, L.-Y., Stanimirovic, A., Encioiu, E., Neill, M., Loblaw, D. A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604054 · Cited by 259 · see citing works

Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes

Alter, B. P. (2007) · Hematology · doi:10.1182/asheducation-2007.1.29 · Cited by 230 · see citing works

Tumor suppressor genes

Hinds, P. W., & Weinberg, R. A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90102-3 · Cited by 207 · see citing works

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR -positive hypereosinophilic syndrome. Results of a multicenter prospective study

Baccarani, M., Cilloni, D., Rondoni, M., Ottaviani, E., Messa, F., Merante, S., Tiribelli, M., Buccisano, F., Testoni, N., Gottardi, E. M., et al. (2007) · Haematologica · doi:10.3324/haematol.11420 · Cited by 194 · see citing works

Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression

Yao, J., Weremowicz, S., Feng, B., Gentleman, R. C., Marks, J. R., Gelman, R. S., Brennan, C. W., & Polyák, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4083 · Cited by 177 · see citing works

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL–negative chronic myeloproliferative disorders

Dávid, M., Cross, N. C. P., Burgstaller, S., Chase, A., Curtis, C., Dang, R. K. B., Gardembas, M., Goldman, J. M., Grand, F., Hughes, G., et al. (2006) · Blood · doi:10.1182/blood-2006-05-024828 · Cited by 174 · see citing works

Is non-isotopic in situ hybridization finally coming of age?

Lichter, P., & Ward, D. C. (1990) · Nature · doi:10.1038/345093a0 · Cited by 137 · see citing works

A Matter of Dosage

Fodde, R., & Smits, R. (2002) · Science · doi:10.1126/science.1077707 · Cited by 129 · see citing works

Mechanisms of transcription factor deregulation in lymphoid cell transformation

O’Neil, J., & Look, A. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210766 · Cited by 122 · see citing works

Single nucleotide polymorphism array analysis of cancer

Dutt, A., & Beroukhim, R. (2006) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a8c1 · Cited by 115 · see citing works

Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas

Okawa, E. R., Gotoh, T., Manne, J., Igarashi, J., Fujita, T., Silverman, K. A., Xhao, H., Mossé, Y. P., White, P. S., & Brodeur, G. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210675 · Cited by 96 · see citing works

Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders

Döhner, K., Hehmann, U., Brown, J. M., Hetzel, C., Stewart, J., Lowther, G. W., Scholl, C., Fröhling, S., Cuneo, A., Tsui, L. ‐., et al. (2001) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-18156-6_3 · Cited by 94 · see citing works

Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders

Döhner, K., Brown, J. M., Hehmann, U., Hetzel, C., Stewart, J., Lowther, G. W., Scholl, C., Fröhling, S., Cuneo, A., Tsui, L., et al. (1998) · Blood · doi:10.1182/blood.v92.11.4031 · Cited by 87 · see citing works

Genetic Pathways in the Pathogenesis of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

Pedersen-Bjergaard, J., Andersen, M. T., & Andersen, M. K. (2007) · Hematology · doi:10.1182/asheducation-2007.1.392 · Cited by 81 · see citing works

Correction for Cimmino et al., miR-15 and miR-16 induce apoptosis by targeting BCL2

(2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510793103 · Cited by 72 · see citing works

Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22

Curtiss, N. P., Bonifas, J. M., Lauchle, J., Balkman, J. D., Kratz, C. P., Emerling, B. M., Green, E. D., Beau, M. M. L., & Shannon, K. (2005) · Genomics · doi:10.1016/j.ygeno.2005.01.013 · Cited by 49 · see citing works

The Theory of APL Revisited

Scaglioni, P. P., & Pandolfi, P. P. (2007) · Springer eBooks · doi:10.1007/978-3-540-34594-7_6 · Cited by 47 · see citing works

Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers

Liu, W., Ewing, C. M., Chang, B., Li, T., Sun, J., Turner, A. R., Dimitrov, L. M., Zhu, Y., Sun, J., Kim, J. W., et al. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20482 · Cited by 46 · see citing works

Identification of Target Genes in Their Native Cellular Context

Owen, L. A., & Lessnick, S. L. (2006) · Cell Cycle · doi:10.4161/cc.5.18.3213 · Cited by 44 · see citing works

Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia‐derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption

Meyer, S., Fergusson, W. D., Whetton, A. D., Moreira-Leite, F. F., Pepper, S. D. V., Miller, C. J., Saunders, E., White, D. J., Will, A., Eden, T. O. B., et al. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20417 · Cited by 37 · see citing works

Conflicting evidence on the frequency of ESR1 amplification in breast cancer

Albertson, D. G. (2008) · Nature Genetics · doi:10.1038/ng0708-821 · Cited by 27 · see citing works

Breaking the rules of cancer

Shaffer, D. R., & Pandolfi, P. P. (2006) · Nature Medicine · doi:10.1038/nm0106-14 · Cited by 22 · see citing works

Erratum: TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J. M., Yudi Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210630 · Cited by 21 · see citing works

Cancer genomics: integrating form and function

Kim, S. Y., & Hahn, W. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm086 · Cited by 20 · see citing works

Broken genes in solid tumours

Meyerson, M. M. (2007) · Nature · doi:10.1038/448545a · Cited by 19 · see citing works

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D. J., Larson, R. A., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,348 · see citing works

Eph receptors and ephrins in cancer: bidirectional signalling and beyond

Pasquale, E. B. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2806 · Cited by 1,216 · see citing works

A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Gröschel, S., Sanders, M. A., Hoogenboezem, R., de Wit, E., Bouwman, B. A. M., Erpelinck, C., van der Velden, V. H. J., Havermans, M., Avellino, R., van Lom, K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.019 · Cited by 687 · see citing works

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

Smallridge, R. C., Marlow, L. A., & Copland, J. A. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0154 · Cited by 392 · see citing works

The role of enhancers in cancer

Sur, I., & Taipale, J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.62 · Cited by 382 · see citing works

The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis

Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L. M., Penney, K. L., Ligon, A. H., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0042 · Cited by 318 · see citing works

SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data

Jia, W., Qiu, K., He, M., Song, P., Zhou, Q., Zhou, F., Yu, Y., Zhu, D., Nickerson, M. L., Wan, S., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-2-r12 · Cited by 206 · see citing works

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

Wilbertz, T., Wagner, P. L., Petersen, K., Stiedl, A., Scheble, V. J., Maier, S. H., Reischl, M., Mikut, R., Altorki, N. K., Moch, H., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.49 · Cited by 198 · see citing works

Primary Malignant Tumors of the Spine

Sundaresan, N., Rosen, G., & Boriani, S. (2008) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2008.10.004 · Cited by 173 · see citing works

The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma

Pechloff, K., Holch, J. W., Ferch, U., Schweneker, M., Brunner, K., Kremer, M., Sparwasser, T. D., Quintanilla‐Martínez, L., Zimber‐Strobl, U., Streubel, B., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092042 · Cited by 164 · see citing works

BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer

Li, X., Baek, G., Ramanand, S. G., Sharp, A., Gao, Y., Yuan, W., Welti, J., Rodrigues, D. N., Dolling, D., Figueiredo, I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.078 · Cited by 148 · see citing works

Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis

Bullinger, L., Krönke, J., Schön, C., Radtke, I., Urlbauer, K., Botzenhardt, U., Gaidzik, V., Carió, A., Senger, C., Schlenk, R. F., et al. (2009) · Leukemia · doi:10.1038/leu.2009.263 · Cited by 137 · see citing works

Collateral lethality: a new therapeutic strategy in oncology

Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132 · see citing works

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies

He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126 · see citing works

The Role of Mechanistic Factors in Promoting Chromosomal Translocations Found in Lymphoid and Other Cancers

Zhang, Y., Gostissa, M., Hildebrand, D. G., Becker, M. S., Boboilă, C., Chiarle, R., Lewis, S. M., & Alt, F. W. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06004-9 · Cited by 123 · see citing works

NCLscan: accurate identification of non-co-linear transcripts (fusion,trans-splicing and circular RNA) with a good balance between sensitivity and precision

Chuang, T., Wu, C.-S., Chen, C.-Y., Hung, L.-Y., Chiang, T.-W., & Yang, M.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1013 · Cited by 122 · see citing works

Health Changes in Fishermen 2 Years After Clean-up of the Prestige Oil Spill

Rodríguez-Trigo, G., Zock, J.-P., Pozo-Rodríguez, F., Gómez, F. P., Monyarch, G., Bouso, L., Coll, M. D., Verea, H., Antó, J. M., Fuster, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00279 · Cited by 94 · see citing works

Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review

Pathak, M. P., Pathak, K., Saikia, R., Gogoi, U., Ahmad, M. Z., Patowary, P., & Das, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112901 · Cited by 90 · see citing works

Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia

Ottema, S., Mulet‐Lazaro, R., Beverloo, H. B., Erpelinck-Verschueren, C. A. J., van Herk, S., van der Helm, R. M., Havermans, M., Grob, T., Valk, P. J. M., Bindels, E. M., et al. (2020) · Blood · doi:10.1182/blood.2019003701 · Cited by 80 · see citing works

Transcriptional control by enhancers and enhancer RNAs

Lewis, M. W., Shen, L., & Franco, H. L. (2019) · Transcription · doi:10.1080/21541264.2019.1695492 · Cited by 78 · see citing works

Gene Copy-Number Variation in Haploid and Diploid Strains of the Yeast Saccharomyces cerevisiae

Zhang, H., Zeidler, A. F., Song, W., Puccia, C. M., Malc, E. P., Greenwell, P. W., Mieczkowski, P. A., Petes, T. D., & Argueso, J. L. (2013) · Genetics · doi:10.1534/genetics.112.146522 · Cited by 78 · see citing works

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: Human papillomavirus-mediated carcinogenesis

Feller, L., Wood, N. H., Khammissa, R. A. G., & Lemmer, J. (2010) · Head & Face Medicine · doi:10.1186/1746-160x-6-14 · Cited by 71 · see citing works

A kernel-based integration of genome-wide data for clinical decision support

Daemen, A., Gevaert, O., Ojeda, F., Debucquoy, A., Suykens, J. A. K., Sempoux, C. L., Machiels, J., Haustermans, K. M., & Moor, B. D. (2009) · Genome Medicine · doi:10.1186/gm39 · Cited by 70 · see citing works

Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase through Multiple Mechanisms

Lisabeth, E. M., Fernandez, C., & Pasquale, E. B. (2012) · Biochemistry · doi:10.1021/bi2014079 · Cited by 67 · see citing works

Oncogenic chromosomal translocations and human cancer (Review)

Zheng, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2677 · Cited by 66 · see citing works

Diagnostic Molecular Biomarkers for Malignant Pleural Effusions

Sriram, K. B., Relan, V., Clarke, B. E., Duhig, E., Yang, I. A., Bowman, R., Lee, G., & Fong, K. M. (2011) · Future Oncology · doi:10.2217/fon.11.45 · Cited by 62 · see citing works

Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements

Krupina, K., Goginashvili, A., & Cleveland, D. W. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00663-0 · Cited by 59 · see citing works

Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck

Göke, F., Bode, M., Franzen, A., Kirsten, R., Goltz, D., Göke, A., Sharma, R. K., Boehm, D., Vogel, W., Wagner, P. L., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.58 · Cited by 58 · see citing works

High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia

Unachukwu, U. J., Chada, K. K., & D'Armiento, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093151 · Cited by 58 · see citing works

Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells

Tadi, S. K., Kari, V., Choudhary, B., Nambiar, M., Akila, T. S., & Raghavan, S. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.140350 · Cited by 57 · see citing works

rSW-seq: Algorithm for detection of copy number alterations in deep sequencing data

Kim, T., Luquette, L. J., Xi, R., & Park, P. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-432 · Cited by 56 · see citing works

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

Despierre, E., Lambrechts, D., Neven, P., Amant, F. C., Lambrechts, S., & Vergote, I. B. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.02.012 · Cited by 55 · see citing works

Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer

Kiang, K. M. Y., Ahad, L., Zhong, X., & Lu, Q. R. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.04.009 · Cited by 54 · see citing works

Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome

Ambatipudi, S., Gerstung, M., Gowda, R., Pai, P., Borges, A. M., Schäffer, A. A., Beerenwinkel, N., & Mahimkar, M. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017250 · Cited by 54 · see citing works

The structural basis for cancer treatment decisions

Nussinov, R., Jang, H., & Tsai, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2439 · Cited by 51 · see citing works

Acute Lymphoblastic Leukemia: Introduction

Pui, C. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.09.011 · Cited by 50 · see citing works

Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors

Göke, F., Franzen, A., Menon, R., Goltz, D., Kirsten, R., Boehm, D., Vogel, W., Göke, A., Scheble, V. J., Ellinger, J., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2943 · Cited by 48 · see citing works

Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical Prostatectomy

Rubio‐Briones, J., Fernández‐Serra, A., Calatrava, A. M., García‐Casado, Z., Rubio, L., Bonillo-García, M. Á., Iborra, I., Solsona, E., & López‐Guerrero, J. A. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.12.096 · Cited by 48 · see citing works

Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective

Russo, E., Spallarossa, A., Tasso, B., Villa, C., & Brullo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126538 · Cited by 47 · see citing works

Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?

Vishwa, R., BharathwajChetty, B., Girisa, S., Aswani, B. S., Alqahtani, M. S., Abbas, M. A. E., Hegde, M., & Kunnumakkara, A. B. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10170-1 · Cited by 47 · see citing works

MicroRNA expression in acute myeloid leukemia

Marcucci, G., Radmacher, M. D., Mrózek, K., & Bloomfield, C. D. (2009) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-009-0012-7 · Cited by 46 · see citing works

Watching the grin fade: Tracing the effects of polyploidy on different evolutionary time scales

Mayfield‐Jones, D., Washburn, J. D., Arias, T., Edger, P. P., Pires, J. C., & Conant, G. C. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.02.002 · Cited by 45 · see citing works

Molecular signatures in acute myeloid leukemia

Mrózek, K., Radmacher, M. D., Bloomfield, C. D., & Marcucci, G. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283257b42 · Cited by 45 · see citing works

Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia

Ernst, T., Score, J., Deininger, M. W., Hidalgo-Curtis, C., Lackie, P. M., Ershler, W. B., Goldman, J. M., Cross, N. C. P., & Grand, F. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08457.x · Cited by 45 · see citing works

Structural chromosomal aberrations as potential risk markers in incident cancer patients

Vodenková, S., Polívková, Z., Mušák, Ľ., Šmerhovský, Z., Zoubková, H., Sytarova, S., Kavcová, E., Halášová, E., Vodičková, Ľ., Jirásková, K., et al. (2015) · Mutagenesis · doi:10.1093/mutage/gev018 · Cited by 44 · see citing works

FuseFISH: Robust Detection of Transcribed Gene Fusions in Single Cells

Semrau, S., Crosetto, N., Bienko, M., Boni, M., BERNASCONI, P. P., Chiarle, R., & van Oudenaarden, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.002 · Cited by 42 · see citing works

Convergent Evolution and the Origin of Complex Phenotypes in the Age of Systems Biology

Washburn, J. D., Bird, K. A., Conant, G. C., & Pires, J. C. (2016) · International Journal of Plant Sciences · doi:10.1086/686009 · Cited by 42 · see citing works

Zinc-chitosan nanoparticles induced apoptosis in human acute T-lymphocyte leukemia through activation of tumor necrosis factor receptor CD95 and apoptosis-related genes

Saravanakumar, K., Elango, J., Chelliah, R., Kathiresan, K., Wu, W., Oh, D., & Wang, M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.017 · Cited by 42 · see citing works

HSP70 colocalizes with PLK1 at the centrosome and disturbs spindle dynamics in cells arrested in mitosis by arsenic trioxide

Chen, Y., Lai, K., Kuo, H., Chow, L., Yih, L., & Lee, T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1222-x · Cited by 41 · see citing works

Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas

Chien, H., Cheng, S., Liao, C., Wang, H., & Huang, S. (2019) · Cancers · doi:10.3390/cancers11060760 · Cited by 41 · see citing works

Dominant-negative mechanism of leukemogenic PAX5 fusions

Kawamata, N., Pennella, M. A., Woo, J. L., Berk, A. J., & Koeffler, H. P. (2011) · Oncogene · doi:10.1038/onc.2011.291 · Cited by 41 · see citing works

Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia

Bochtler, T., Fröhling, S., & Krämer, A. (2015) · Leukemia · doi:10.1038/leu.2015.32 · Cited by 39 · see citing works

Pathology, genetics and cytogenetics of Wilms’ tumour

Zin, R. M., Murch, A. R., & CHARLES, A. K. (2011) · Pathology · doi:10.1097/pat.0b013e3283463575 · Cited by 39 · see citing works

State of the Art Management in Spine Oncology

Sundaresan, N., Boriani, S., & Okuno, S. H. (2009) · Spine · doi:10.1097/brs.0b013e3181bac476 · Cited by 39 · see citing works

PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice

Welch, J. S., Yuan, W., & Ley, T. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42953 · Cited by 38 · see citing works

Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer

Schröck, A., Göke, F., Wagner, P. L., Bode, M., Franzen, A., Huss, S., Agaimy, A., Ihrler, S., Kirsten, R., Kristiansen, G., et al. (2013) · Head & Neck · doi:10.1002/hed.23443 · Cited by 38 · see citing works

Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis

Heiland, D. H., Staszewski, O., Hirsch, M., Masalha, W., Franco, P., Grauvogel, J., Capper, D., Schrimpf, D., Urbach, H., & Weyerbrock, A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw007 · Cited by 38 · see citing works

Sex Determining Region Y-Box 2 (SOX2) Amplification Is an Independent Indicator of Disease Recurrence in Sinonasal Cancer

Schröck, A., Göke, F., Wagner, P. L., Bode, M., Franzen, A., Braun, M., Huss, S., Agaimy, A., Ihrler, S., Menon, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059201 · Cited by 37 · see citing works

An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network

Liang, Y. J., Xu, P., Zou, Q., Luo, H., & Yu, W. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.004 · Cited by 37 · see citing works

Comparative Oncogenomic Analysis of Copy Number Alterations in Human and Zebrafish Tumors Enables Cancer Driver Discovery

Zhang, G., Hoersch, S., Amsterdam, A., Whittaker, C. A., Beert, E., Catchen, J., Farrington, S. M., Postlethwait, J. H., Legius, E., Hopkins, N. H., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003734 · Cited by 34 · see citing works

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice

Kim, O., Park, E. Y., Klinkebiel, D. L., Pack, S., Shin, Y.-H., Abdullaev, Z., Emerson, R. E., Coffey, D. M., Kwon, S. Y., Creighton, C. J., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008808 · Cited by 33 · see citing works

Inhibition of G1 to S Phase Progression by a Novel Zinc Finger Protein P58TFL at P-bodies

Minagawa, K., Katayama, Y., Nishikawa, S., Yamamoto, K., Sada, A., Okamura, A., Shimoyama, M., & Matsui, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0511 · Cited by 33 · see citing works

The Ty1 transposition assay: a new short-term test for detection of carcinogens

Pesheva, M. G., Krastanova, O., Staleva, L., Dentcheva, V., Hadzhitodorov, M., & Venkov, P. (2004) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2004.10.001 · Cited by 33 · see citing works

Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives

Sugimura, H., Mori, H., Nagura, K., Kiyose, S., Hong, T., Isozaki, M., Igarashi, H., Shinmura, K., Hasegawa, A., Kitayama, Y., et al. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02561.x · Cited by 32 · see citing works

Therapeutic potential of siRNA and DNAzymes in cancer

Karnati, H. K., Yalagala, R. S., Undi, R. B., Pasupuleti, S. R., & Gutti, R. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2477-9 · Cited by 32 · see citing works

Targeted therapy of chronic myeloid leukemia

Sullivan, C., Peng, C., Chen, Y., Li, D., & Li, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.001 · Cited by 32 · see citing works

An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network

Liang, Y. J., Xu, P., Zou, Q., Luo, H., & Yu, W. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.001 · Cited by 32 · see citing works

Comparative analysis of algorithms for integration of copy number and expression data

Louhimo, R., Lepikhova, T., Monni, O., & Hautaniemi, S. (2012) · Nature Methods · doi:10.1038/nmeth.1893 · Cited by 30 · see citing works

Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

Bayani, J., Marrano, P. M., Graham, C., Zheng, Y., Li, L., Katsaros, D., Lassus, H. J., Bützow, R. C., Squire, J. A., & Diamandis, E. P. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.08.002 · Cited by 30 · see citing works

Advanced Cancer: Emergence of a New Survivor Population

Haylock, P. J. (2010) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2010.05.008 · Cited by 30 · see citing works

Viewing the Eph receptors with a focus on breast cancer heterogeneity

Nikas, I. P., Ryu, H. S., & Theocharis, S. E. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.030 · Cited by 30 · see citing works

Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade

Mochizuki, H., Thomas, R. J., Moroff, S. D., & Breen, M. (2017) · Chromosome Research · doi:10.1007/s10577-016-9543-7 · Cited by 28 · see citing works

Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies

Weng, S., Stoner, S. A., & Zhang, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12050 · Cited by 28 · see citing works

Genetic deletions in AML and MDS

Ebert, B. L. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.09.006 · Cited by 27 · see citing works

Lifetime Follow-up Care After Childhood Cancer

Haddy, R. I., & Haddy, T. B. (2010) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2010.05.100031 · Cited by 27 · see citing works

A time stamp comparative analysis of frequent chromosomal abnormalities in Romanian patients

Suciu, N., & Plăiaşu, V. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.794215 · Cited by 27 · see citing works

Cytogenomics of cancers: From chromosome to sequence

Bernheim, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.003 · Cited by 27 · see citing works

MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias

Marcucci, G., Mrózek, K., Radmacher, M. D., Bloomfield, C. D., & Croce, C. M. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.05.003 · Cited by 27 · see citing works

Ubc4 and Not4 Regulate Steady-State Levels of DNA Polymerase-α to Promote Efficient and Accurate DNA Replication

Haworth, J. C., Alver, R. C., Anderson, M. A., & Bielinsky, A. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0452 · Cited by 26 · see citing works

Loss of 5q in myeloid malignancies – A gain in understanding of biological and clinical consequences

Venugopal, S., Mascarenhas, J. O., & Steensma, D. P. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100735 · Cited by 25 · see citing works

Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma

Humtsoe, J. O., Kim, H., Jones, L., Cevallos, J., Boileau, P., Kuo, F., Morris, L. G. T., & Ha, P. K. (2022) · Cancers · doi:10.3390/cancers14092263 · Cited by 25 · see citing works

RNA interference as an anticancer therapy: a patent perspective

Dykxhoorn, D. M. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902838008 · Cited by 25 · see citing works

Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction

Mochizuki, H., Shapiro, S. G., & Breen, M. (2015) · Veterinary Pathology · doi:10.1177/0300985815614975 · Cited by 25 · see citing works

SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy

Naumann, J. A., Widen, J. C., Jonart, L. A., Ebadi, M., Tang, J. H., Gordon, D. J., Harki, D. A., & Gordon, P. M. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00774 · Cited by 23 · see citing works

Y Chromosome Loss and Implications for Oncology

Dirican, C. D., & Nelson, P. S. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0105 · Cited by 22 · see citing works

Follow-Up Genotoxic Study: Chromosome Damage Two and Six Years after Exposure to the Prestige Oil Spill

Hildur, K., Templado, C., Zock, J., Giraldo, J., Pozo-Rodrı́guez, F., Francés, A., Monyarch, G., Rodríguez-Trigo, G., Rodríguez-Rodríguez, E., Souto-Alonso, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132413 · Cited by 22 · see citing works

Cytogenetic analysis of an exposed-referent study: perchloroethylene-exposed dry cleaners compared to unexposed laundry workers

Tucker, J. D., Sorensen, K. J., Ruder, A. M., McKernan, L. T., Forrester, C. L., & Butler, M. A. (2011) · Environmental Health · doi:10.1186/1476-069x-10-16 · Cited by 22 · see citing works

Quantitative detection of rare interphase chromosome breaks and translocations by high-throughput imaging

Burman, B., Misteli, T., & Pegoraro, G. (2015) · Genome biology · doi:10.1186/s13059-015-0718-x · Cited by 21 · see citing works

Drug conjugated nanoparticles activated by cancer cell specific mRNA

Gossai, N. P., Naumann, J. A., Li, N., Zamora, E. A., Gordon, D. J., Piccirilli, J. A., & Gordon, P. M. (2016) · Oncotarget · doi:10.18632/oncotarget.9430 · Cited by 21 · see citing works

Chromosomal Bands Affected by Acute Oil Exposure and DNA Repair Errors

Monyarch, G., Reis, F. D. C., Zock, J., Giraldo, J., Pozo-Rodrı́guez, F., Espinosa, A., Rodríguez-Trigo, G., Verea, H., Castaño‐Vinyals, G., Gómez, F. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081276 · Cited by 20 · see citing works

Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution

Benchikh, S., Bousfiha, A., Hamouchi, A. E., Soro, S. G. C., Malki, A., & Nassereddine, S. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00248-2 · Cited by 20 · see citing works

Chromosome translocations and assessing human exposure to adverse environmental agents

Tucker, J. D. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20561 · Cited by 20 · see citing works

Chromosomal instability and cancer: not just one CINgle mechanism

Boland, C. R., Komarova, N. L., & Goel, A. (2009) · Gut · doi:10.1136/gut.2008.160143 · Cited by 20 · see citing works

The search for cis-regulatory driver mutations in cancer genomes

Poulos, R. C., Sloane, M. A., Hesson, L. B., & Wong, J. W. H. (2015) · Oncotarget · doi:10.18632/oncotarget.5085 · Cited by 20 · see citing works

Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil

Francés, A., Hildur, K., Barberà, J. A., Rodríguez-Trigo, G., Zock, J., Giraldo, J., Monyarch, G., Rodríguez-Rodríguez, E., Reis, F. D. C., Souto-Alonso, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159404 · Cited by 20 · see citing works

Prostate cancer: The revolution of the fusion genes

Fernández‐Serra, A., Rubio‐Briones, J., García‐Casado, Z., Solsona, E., & López‐Guerrero, J. A. (2011) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2010.11.001 · Cited by 19 · see citing works

The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy

Pathania, A. S., Chava, H., Balusu, R., Pasupulati, A. K., Coulter, D. W., & Challagundla, K. B. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200785 · Cited by 19 · see citing works

Genes with Relevance for Early to Late Progression of Colon Carcinoma Based on Combined Genomic and Transcriptomic Information from the Same Patients

Lagerstedt, K. K., Kristiansson, E., Lönnroth, C., Andersson, M., Iresjö, B., Gustafsson, A., Hansson, E., Kressner, U., Nordgren, S., Enlund, F., et al. (2010) · Cancer Informatics · doi:10.4137/cin.s4545 · Cited by 19 · see citing works

Cáncer de próstata: la revolución de los genes de fusión

Fernández‐Serra, A., Rubio‐Briones, J., García‐Casado, Z., Solsona, E., & López‐Guerrero, J. A. (2011) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2010.11.019 · Cited by 19 · see citing works

NCLcomparator: systematically post-screening non-co-linear transcripts (circular, trans-spliced, or fusion RNAs) identified from various detectors

Chen, C.-Y., & Chuang, T. (2019) · BMC Bioinformatics · doi:10.1186/s12859-018-2589-0 · Cited by 19 · see citing works

Chromosome changes in cancer.

Mitelman, F. (1986) · PubMed · Cited by 4 · see citing works

Cancer: Chromosomal Abnormalities

Mitelman, F. (2010) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0005552.pub2 · Cited by 1 · see citing works

CANCER AND CHROMOSOMES

Tanaka, K., & Kamada, N. (1968) · The Sciences · doi:10.1002/j.2326-1951.1968.tb00382.x · Cited by 1 · see citing works

[Chromosomal aberrations in hematologic neoplasia].

Oguma, N. (1992) · PubMed

Chromosomal breakpoints hit the spot

Rabbitts, T. H. (1997) · Nature Medicine · doi:10.1038/nm0597-496 · Cited by 4 · see citing works